GCIA
CDIO icon

Gabelli & Co Investment Advisers’s Cardio Diagnostics CDIO Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,533
Closed -$461K – 301
2022
Q3 		$461K Hold
1,533
– – 0.06% 214
2022
Q2 		$457K Hold
1,533
– – 0.06% 233
2022
Q1 		$455K Buy
+1,533
New +$453K 0.06% 238

Other funds holding CDIO

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.61% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $265M AUM 30.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Gabelli & Co Investment Advisers's CDIO Position: Q4 2022 in Review

Gabelli & Co Investment Advisers sold out of Cardio Diagnostics (CDIO) in Q4 2022, closing a stake of 1,533 shares — an estimated $461K sold.

Gabelli & Co Investment Advisers first reported a position in CDIO in Q1 2022 and held it in 3 quarters. The position peaked at $461K in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q4 2022.

  • Gabelli & Co Investment Advisers reported no remaining Cardio Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 1,533 Cardio Diagnostics shares in Q4 2022, an estimated $461K.
  • Gabelli & Co Investment Advisers first reported a position in Cardio Diagnostics in Q1 2022 and held it in 3 quarters.
  • Gabelli & Co Investment Advisers's Cardio Diagnostics position peaked at $461K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q4 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.